BAUMANN OLIVER ROLF purchased 0.9% of their position (50K shares) of VERAXA BIOTECH HOLDING AG on the open market
Open‑market purchase worth $75.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/31/2026ACC: 0001829126-26-009544
Director
Since Jun 2026
+50K
Net shares
Net buyer
$75.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
+50K
Price / share
$1.50
Trade value
$75K
% of position
0.9%
8/27/2026
5.72M→5.77M
Total
Net shares
+50K
Net value
$75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 8/27/2026 | P · Purchase | +50K | $1.50 | $75K | 0.9% | 5.72M | 5.77M |
| Total | +50K | $75K | ||||||
Derivative Transactions0
No derivative transactions reported